|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.296
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.201
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.163
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.160
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.149
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.149
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.139
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.100
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.097
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.094
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.093
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.092
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.088
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.086
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.080
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.072
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.070
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.067
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.067
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.065
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.064
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.060
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.058
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.056
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.056
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.052
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.051
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.050
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.048
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.047
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.046
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.043
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.043
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.042
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.039
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.039
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.039
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.039
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.038
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
histone h4 k20 methylation
|
GO:0034770 |
8 |
0.037
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.037
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.037
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.036
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.036
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.036
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.034
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.034
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
centrosome separation
|
GO:0051299 |
4 |
0.032
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.032
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.032
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.031
|
|
|
|
histone h3 k9 trimethylation
|
GO:0036124 |
6 |
0.031
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.030
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.030
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.030
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.030
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.029
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.029
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.029
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.029
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.029
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.029
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.028
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.027
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.027
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.027
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.027
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.026
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.026
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.025
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.025
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.025
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.025
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.025
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.025
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.025
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.025
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.025
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.024
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.024
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.024
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.023
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.023
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.022
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.022
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.022
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.022
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.022
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.021
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.021
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.021
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.021
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.021
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.020
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.020
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.020
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.020
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.020
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.020
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.020
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.019
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.019
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.019
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.019
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.018
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.018
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.018
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.018
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.018
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.018
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.018
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.017
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.017
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.017
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.017
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.017
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.017
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.017
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.017
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.017
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.017
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.017
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.017
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.017
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.016
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.016
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.016
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.016
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.016
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.016
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.016
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.016
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.016
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.015
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.015
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.015
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.015
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.015
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.015
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.015
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.015
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.015
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.015
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.015
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.015
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.015
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.014
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.014
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.014
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.014
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.014
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.014
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.014
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.014
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.014
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.014
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.014
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.014
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.013
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.013
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.013
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.013
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.013
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.013
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.013
|
|
|
|
negative regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902443 |
3 |
0.013
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.013
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.013
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.013
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.013
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.013
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.013
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.013
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.013
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.013
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.012
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.012
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.012
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.012
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.012
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.012
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.012
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.012
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.012
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.012
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.012
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.012
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.012
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.012
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.012
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.012
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.012
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.012
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.012
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.012
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.012
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.012
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.012
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.011
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.011
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.011
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.011
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.011
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.011
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.011
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.011
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.011
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.011
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.011
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.011
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.011
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.011
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.011
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.011
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.011
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.011
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.011
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.011
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.011
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.011
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.011
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.011
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.011
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.011
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.011
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.011
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.011
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.011
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.011
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.011
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.010
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.010
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.010
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.010
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.010
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.010
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.010
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.010
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.010
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.010
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.010
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.010
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.010
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.010
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.010
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.010
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.010
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.010
|
|
